Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.
Autores de CIPF
Participantes ajenos a CIPF
- Torregrosa I
- Andrés-Costa MJ
- Giménez-Garzó C
- Juan I
- Puchades MJ
- Blasco ML
- Carratalá A
- Sanjuán R
- Miguel A
Grupos de Investigación
Abstract
Acute kidney injury (AKI) is a common complication after coronary angiography. Early biomarkers of this disease are needed since increase in serum creatinine levels is a late marker. To assess the usefulness of urinary kidney injury molecule-1 (uKIM-1), neutrophil gelatinase-associated lipocalin (uNGAL) and liver-type fatty acid-binding protein (uL-FABP) for early detection of AKI in these patients, comparing their performance with another group of cardiac surgery patients. Biomarkers were measured in 193 patients, 12 h after intervention. In the ROC analysis, AUC for KIM-1, NGAL and L-FABP was 0.713, 0.958 and 0.642, respectively, in the coronary angiography group, and 0.716, 0.916 and 0.743 in the cardiac surgery group. Urinary KIM-1 12 h after intervention is predictive of AKI in adult patients undergoing coronary angiography, but NGAL shows higher sensitivity and specificity. L-FABP provides inferior discrimination for AKI than KIM-1 or NGAL in contrast to its performance after cardiac surgery. This is the first study showing the predictive capacity of KIM-1 for AKI after coronary angiography. Further studies are still needed to answer relevant questions about the clinical utility of biomarkers for AKI in different clinical settings.
Datos de la publicación
- ISSN/ISSNe:
- 0910-8327, 1615-2573
- Tipo:
- Article
- Páginas:
- 703-711
- PubMed:
- 24989970
HEART AND VESSELS SPRINGER
Citas Recibidas en Web of Science: 59
Documentos
- No hay documentos
Filiaciones
Keywords
- Acute kidney injury, Biomarkers, Cardiac surgery, Coronary angiography, KIM-1, L-FABP, NGAL
Proyectos asociados
Identificación de un panel de metabolitos en sangre útil par
Investigador Principal: VICENTE FELIPO ORTS
CONSELLERIA DE SANIDAD . 2015